NIH-funded research R01 grant

Creating a fully implantable heart pump for young children with heart failure

Official title: Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility

Funded at Texas Heart Institute · NIH-10661591 · Data updated 2026-11-12

This study is working on a new, smaller heart pump called NeoVAD that can be safely implanted in babies and young kids with heart failure, making it easier for them to wait for a heart transplant without the risks of larger devices.

More Heart Failure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Heart Institute
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2020
Project endJune 30, 2025
Funding year2023
Award (this year)$787,884
NIH project number5R01HL153538-04
Project IDNIH-10661591 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants and young children diagnosed with heart failure, particularly those who are too small for existing VADs.

Less likely to help

Patients who are older than 21 years or those who do not have heart failure will not benefit from this research.

What this research studies

This research focuses on developing a fully implantable ventricular assist device (VAD) specifically designed for infants and young children suffering from heart failure. Current VADs are too large for children under four years old and require external components that can lead to infections and prolonged hospital stays. The new device, called NeoVAD, aims to be smaller, safer, and adjustable to accommodate a child's growth, ultimately improving their chances of survival while waiting for a heart transplant. The project involves innovative engineering and design to ensure the device is both effective and compatible with the unique needs of pediatric patients.

Why it matters

Potential benefit: If successful, this research could significantly improve survival rates and quality of life for infants and young children with heart failure.

How similar studies have gone: While there have been advancements in VAD technology, this specific approach for fully implantable devices in pediatric patients is novel and has not been extensively tested.

Where this research is happening

  • Texas Heart Institute
    Houston, United States
    Active

Researchers

  • Principal investigator: Frazier, O. H. — Texas Heart Institute
  • Study coordinator: Frazier, O. H.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.